• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因骨髓移植后的药物性肝损伤。

Drug-induced liver injury after allogeneic bone marrow transplantation.

机构信息

Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan,

出版信息

Int J Hematol. 2013 Oct;98(4):499-503. doi: 10.1007/s12185-013-1434-5. Epub 2013 Sep 15.

DOI:10.1007/s12185-013-1434-5
PMID:24037455
Abstract

A 23-year-old woman developed acute severe hepatitis and jaundice on day 183 after bone marrow transplantation from HLA-B antigen mismatched-related donor. The administration of prednisolone and cessation of the prescribed drugs resolved the liver injury. Drug lymphocyte stimulation test was positive for acyclovir, and liver biopsy indicated the characteristics of drug-induced liver injury (DILI) rather than graft-versus-host disease. Physicians should keep DILI in mind when considering differential diagnosis for liver complications after allogeneic cell transplantation.

摘要

一位 23 岁女性在接受 HLA-B 抗原不匹配相关供者骨髓移植后 183 天出现急性重症肝炎和黄疸。应用泼尼松龙和停用规定药物后肝损伤得到缓解。药物淋巴细胞刺激试验提示阿昔洛韦阳性,肝活检提示药物性肝损伤(DILI)的特征,而非移植物抗宿主病。对于异基因细胞移植后肝脏并发症的鉴别诊断,医生应考虑到 DILI。

相似文献

1
Drug-induced liver injury after allogeneic bone marrow transplantation.异基因骨髓移植后的药物性肝损伤。
Int J Hematol. 2013 Oct;98(4):499-503. doi: 10.1007/s12185-013-1434-5. Epub 2013 Sep 15.
2
Acute abdominal pain preceding cutaneous manifestations of varicella zoster infection after allogeneic bone marrow transplantation.
Tohoku J Exp Med. 2001 Sep;195(1):61-3. doi: 10.1620/tjem.195.61.
3
Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.异基因骨髓移植后的水痘带状疱疹病毒感染:发生率、危险因素及临床结局
Biol Blood Marrow Transplant. 2000;6(1):44-9. doi: 10.1016/s1083-8791(00)70051-6.
4
CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.来自基因分型 HLA 不相同的相关供体的 CD6+ T 细胞耗竭的异基因骨髓移植。
Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.
5
Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.异基因骨髓移植后的水痘-带状疱疹感染:发病率、危险因素以及低剂量阿昔洛韦和更昔洛韦的预防作用
Bone Marrow Transplant. 2000 Mar;25(6):657-64. doi: 10.1038/sj.bmt.1702190.
6
Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.长期小剂量阿昔洛韦预防异基因造血干细胞移植后水痘带状疱疹病毒再激活
Bone Marrow Transplant. 2001 Oct;28(7):689-92. doi: 10.1038/sj.bmt.1703214.
7
Pulmonary veno-occlusive disease following reduced-intensity allogeneic bone marrow transplantation for acute myeloid leukemia.急性髓系白血病减低强度异基因骨髓移植后的肺静脉闭塞病
Intern Med. 2012;51(2):195-8. doi: 10.2169/internalmedicine.51.6302. Epub 2012 Jan 15.
8
Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient.一名异基因骨髓移植患者在接受皮节带状疱疹治疗后发生水痘带状疱疹性脑膜炎。
Bone Marrow Transplant. 2000 Oct;26(7):795-6. doi: 10.1038/sj.bmt.1702599.
9
Acyclovir treatment of herpes zoster infections. Use in children undergoing bone marrow transplantation.阿昔洛韦治疗带状疱疹感染。用于接受骨髓移植的儿童。
JAMA. 1982 Apr 16;247(15):2132-5.
10
Varicella-zoster virus infection under administration of ganciclovir after allogeneic bone marrow transplantation.
Scand J Infect Dis. 2006;38(3):227-8. doi: 10.1080/00365540500348986.

本文引用的文献

1
Risk and prognostic factors for acute GVHD based on NIH consensus criteria.根据 NIH 共识标准的急性移植物抗宿主病的风险和预后因素。
Bone Marrow Transplant. 2013 Apr;48(4):587-92. doi: 10.1038/bmt.2012.187. Epub 2012 Sep 24.
2
Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.肝移植后药物性肝损伤的频率、临床表现和结局。
Liver Transpl. 2012 Jul;18(7):803-10. doi: 10.1002/lt.23424.
3
Case definition and phenotype standardization in drug-induced liver injury.药物性肝损伤的病例定义和表型标准化。
Clin Pharmacol Ther. 2011 Jun;89(6):806-15. doi: 10.1038/clpt.2011.58. Epub 2011 May 4.
4
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后伏立康唑的肝脏安全性。
Biol Blood Marrow Transplant. 2010 Jan;16(1):46-52. doi: 10.1016/j.bbmt.2009.08.015. Epub 2009 Oct 9.
5
Biomarkers for the diagnosis and management of drug-induced liver injury.用于药物性肝损伤诊断和管理的生物标志物。
Semin Liver Dis. 2009 Nov;29(4):393-9. doi: 10.1055/s-0029-1240008. Epub 2009 Oct 13.
6
Practical guidelines for diagnosis and early management of drug-induced liver injury.药物性肝损伤诊断与早期管理实用指南
World J Gastroenterol. 2008 Nov 28;14(44):6774-85. doi: 10.3748/wjg.14.6774.
7
Recent status of drug-induced liver injury.药物性肝损伤的研究现状。
Hepatol Res. 2009 Jan;39(1):1-6. doi: 10.1111/j.1872-034X.2008.00400.x. Epub 2008 Jul 4.
8
Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.用于药物性肝损伤因果关系评估的Naranjo药物不良反应概率量表评价
Aliment Pharmacol Ther. 2008 May;27(9):780-9. doi: 10.1111/j.1365-2036.2008.03655.x. Epub 2008 Feb 18.
9
Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation.基于白消安/环磷酰胺的异基因造血干细胞移植后肝毒性的药物遗传学分析
Anticancer Res. 2007 Nov-Dec;27(6C):4377-80.
10
A clinical-pathological analysis of drug-induced hepatic injury after liver transplantation.肝移植后药物性肝损伤的临床病理分析
Transplant Proc. 2007 Dec;39(10):3287-91. doi: 10.1016/j.transproceed.2007.08.096.